Novo Nordisk
NVO
525 hedge funds and large institutions have $11B invested in Novo Nordisk in 2015 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 183 increasing their positions, 187 reducing their positions, and 36 closing their positions.
33% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 36
3% more funds holding in top 10
Funds holding in top 10: 31 → 32 (+1)
2% more funds holding
Funds holding: 516 → 525 (+9)
0.17% less ownership
Funds ownership: 19.92% → 19.75% (-0.17%)
2% less capital invested
Capital invested by funds: $11.2B → $11B (-$204M)
2% less repeat investments, than reductions
Existing positions increased: 183 | Existing positions reduced: 187
59% less call options, than puts
Call options by funds: $9.93M | Put options by funds: $24.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$300M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$101M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$63.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$55M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$26.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$92.7M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$85.7M |
| 3 |
Renaissance Technologies
New York
|
-$51.9M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
-$36.4M |
| 5 |
Bank of New York Mellon
New York
|
-$32.3M |
NVO Hedge Fund Activity: Q3 2015 in Review
525 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2015, worth a combined $11B — down 1.8% from $11.2B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new NVO positions and 36 closed out — a net gain of 12 holders — while 183 added to existing stakes and 187 trimmed.
The largest buyer was Bank of America, adding an estimated $300M. The largest seller was Jennison Associates, cutting an estimated $92.7M.
- 525 institutional investors held Novo Nordisk (NVO) as of Q3 2015, up from 516 in Q2 2015.
- Funds reported $11B of Novo Nordisk stock for Q3 2015, down 1.8% quarter-over-quarter.
- 48 funds opened new Novo Nordisk positions in Q3 2015 and 36 closed out, a net change of +12 holders.
- The largest Novo Nordisk buyer in Q3 2015 was Bank of America, an estimated $300M added.
- The largest Novo Nordisk seller in Q3 2015 was Jennison Associates, an estimated $92.7M sold.
Based on aggregated 13F filings for Q3 2015.